Inflammatory markers in a 2-year soy intervention among premenopausal women

Journal of Inflammation

Volumn 6, Issue , 2009, Pages

  Maskarinec, Gertraud ^a   Steude, Jana S ^a   Franke, Adrian A ^a   Cooney, Robert V ^a  

^a UNIVERSITY OF HAWAII CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN; INTERLEUKIN 6; ISOFLAVONE DERIVATIVE; LEPTIN;

ADULT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BREAST CANCER; CARCINOGENESIS; CHRONIC INFLAMMATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNE RESPONSE; NORMAL HUMAN; OBESITY; PREMENOPAUSE; RANDOMIZED CONTROLLED TRIAL; SOYBEAN;

EID: 65349095756     PISSN: None     EISSN: 14769255     Source Type: Journal    
DOI: 10.1186/1476-9255-6-9     Document Type: Article

References (47)

1. The role of soy products in reducing risk of cancer. M Messina S Barnes, J Natl Cancer Inst 1991 83 541 546 10.1093/jnci/83.8.541 1672382
2. Phyto-oestrogens and cancer. H Adlercreutz, Lancet Oncol 2002 3 364 373 10.1016/S1470-2045(02)00777-5 12107024 (Pubitemid 34661986)
3. Meta-analysis of soy intake and breast cancer risk. BJ Trock L Hilakivi-Clarke R Clarke, J Natl Cancer Inst 2006 98 459 471 16595782
4. Epidemiology of soy exposures and breast cancer risk. AH Wu MC Yu CC Tseng MC Pike, Br J Cancer 2008 98 9 14 10.1038/sj.bjc.6604145 18182974
5. Soy isoflavones - phytoestrogens and what else? S Barnes, J Nutr 2004 134 1225S 1228S 15113976
6. Effects of a 2-year randomized soy intervention on sex hormone levels in premenopausal women. G Maskarinec AA Franke AE Williams S Hebshi C Oshiro SP Murphy FZ Stanczyk, Cancer Epidemiol Biomarkers Prev 2004 13 1736 1744 15533901 (Pubitemid 39482950)
7. Soy isoflavones exert modest hormonal effects in premenopausal women. AM Duncan BE Merz X Xu TC Nagel WR Phipps MS Kurzer, J Clin Endocrinol Metab 1999 84 192 197 10.1210/jc.84.1.192 9920082 (Pubitemid 29036700)
8. The specific role of isoflavones on estrogen metabolism in premenopausal women. NB Kumar A Cantor K Allen D Riccardi CE Cox, Cancer 2002 94 1166 1174 11920488 10.1002/cncr.10320 (Pubitemid 34150873)
9. A controlled 2-mo dietary fat reduction and soy food supplementation study in postmenopausal women. AH Wu FZ Stanczyk C Martinez CC Tseng S Hendrich P Murphy S Chaikittisilpa DO Stram MC Pike, Am J Clin Nutr 2005 81 1133 1141 15883439 (Pubitemid 41724956)
10. No relationship between circulating levels of sex steroids and mammographic breast density: the Prospect-EPIC cohort. M Verheus PH Peeters PA Van Noord YT van der Schouw DE Grobbee CH van Gils, Breast Cancer Res 2007 9 R53 17692133 10.1186/bcr1758 (Pubitemid 350187470)
11. Circulating levels of inflammatory markers and cancer risk in the health aging and body composition cohort. D Il'yasova LH Colbert TB Harris AB Newman DC Bauer S Satterfield SB Kritchevsky, Cancer Epidemiol Biomarkers Prev 2005 14 2413 2418 10.1158/1055-9965.EPI-05-0316 16214925 (Pubitemid 41437845)
12. Molecular links between obesity and breast cancer. AM Lorincz S Sukumar, Endocr Relat Cancer 2006 13 279 292 10.1677/erc.1.00729 16728564 (Pubitemid 43886659)
13. Soy isoflavones modulate immune function in healthy postmenopausal women. TA Ryan-Borchers JS Park BP Chew MK McGuire LR Fournier KA Beerman, Am J Clin Nutr 2006 83 1118 1125 16685055
14. Effect of genistein and daidzein on platelet aggregation and monocyte and endothelial function. N Gottstein BA Ewins C Eccleston GP Hubbard IC Kavanagh AM Minihane PD Weinberg G Rimbach, Br J Nutr 2003 89 607 616 10.1079/BJN2003820 12720581 (Pubitemid 36592088)
15. Effects of oral soy protein on markers of inflammation in postmenopausal women with mild hypercholesterolemia. A Blum N Lang A Peleg F Vigder P Israeli M Gumanovsky S Lupovitz A Elgazi M Ben Ami, Am Heart J 2003 145 e7 10.1067/mhj.2003.115 12595862
16. Genistein as an anti-inflammatory agent. M Verdrengh IM Jonsson R Holmdahl A Tarkowski, Inflamm Res 2003 52 341 346 10.1007/s00011-003-1182-8 14504672 (Pubitemid 36995159)
17. Differential regulation of protein tyrosine kinase on free radical production, granule enzyme release, and cytokine synthesis by activated murine peritoneal macrophages. YK Kim YY Jang DH Kim HH Ko ES Han CS Lee, Biochem Pharmacol 2001 61 87 96 10.1016/S0006-2952(00)00531-1 11137713 (Pubitemid 32013959)
18. A 2-year soy intervention in premenopausal women does not change mammographic densities. G Maskarinec Y Takata AA Franke AE Williams SP Murphy, J Nutr 2004 134 3089 3094 15514280 (Pubitemid 39470089)
19. Epidemiology of cytokines: the Women On the Move through Activity and Nutrition (WOMAN) Study. E Wong M Freiberg R Tracy L Kuller, Am J Epidemiol 2008 168 443 453 10.1093/aje/kwn132 18579536
20. Obesity and immune function relationships. A Marti A Marcos JA Martinez, Obes Rev 2001 2 131 140 10.1046/j.1467-789x.2001.00025.x 12119664 (Pubitemid 33755922)
21. Leptin and cancer. C Garofalo E Surmacz, J Cell Physiol 2006 207 12 22 10.1002/jcp.20472 16110483
22. Adiponectin: a key fat-derived molecule regulating inflammation. H Tilg AM Wolf, Expert Opin Ther Targets 2005 9 245 251 10.1517/14728222.9.2.245 15934913 (Pubitemid 40613866)
23. Isoflavone levels in soy foods consumed by multiethnic populations in Singapore and Hawaii. AA Franke JH Hankin MC Yu G Maskarinec SH Low LJ Custer, J Agric Food Chem 1999 47 977 986 10.1021/jf9808832 10552401 (Pubitemid 29182948)
24. HPLC analysis of isoflavonoids and other phenolic agents from foods and from human fluids. AA Franke LJ Custer W Wang SJ Shi, Proc Soc Exp Biol Med 1998 217 263 273 9492334 (Pubitemid 28130672)
25. Three measures show high compliance in soy intervention among premenopausal women. G Maskarinec C Robbins B Riola L Kane-Sample A Franke S Murphy, J Am Diet Assoc 2003 103 861 866 10.1016/S0002-8223(03)00377-8 12830025 (Pubitemid 44332343)
26. RC Littell GA Milliken WW Stroup RD Wolfinger, SAS system for mixed models Cary, NC: SAS Institute Inc 1996
27. SAS Institute Inc, SAS OnlineDoc 9.1.2 Cary, NC: SAS Institute Inc 2004
28. JD Singer JB Willett, Applied longitudinal data analysis: Modeling change and event occurrence Oxford: Oxford University Press 2003
29. Effects of high- and low-isoflavone soyfoods on blood lipids, oxidized LDL, homocysteine, and blood pressure in hyperlipidemic men and women. DJ Jenkins CW Kendall CJ Jackson PW Connelly T Parker D Faulkner E Vidgen SC Cunnane LA Leiter RG Josse, Am J Clin Nutr 2002 76 365 372 12145008
30. Evidence of a lack of effect of a phytoestrogen regimen on the levels of C-reactive protein, E-selectin, and nitrate in postmenopausal women. E Nikander M Metsa-Heikkila A Tiitinen O Ylikorkala, J Clin Endocrinol Metab 2003 88 5180 5185 10.1210/jc.2003-030362 14602747 (Pubitemid 37455409)
31. The effect of the phytoestrogen genistein and hormone replacement therapy on homocysteine and C-reactive protein level in postmenopausal women. R D'Anna G Baviera F Corrado F Cancellieri A Crisafulli F Squadrito, Acta Obstet Gynecol Scand 2005 84 474 477 10.1111/j.0001-6349.2005.00661.x 15842212 (Pubitemid 40663448)
32. Consumption of isoflavone-rich soy protein does not alter homocysteine or markers of inflammation in postmenopausal women. KA Greany JA Nettleton KE Wangen W Thomas MS Kurzer, Eur J Clin Nutr 2007 62 1419 1425 10.1038/sj.ejcn.1602885 17805230
33. Impact of soy supplementation on sex steroids and vascular inflammation markers in postmenopausal women using tibolone: role of equol production capability. R Tormala S Appt TB Clarkson AO Mueck H Seeger TS Mikkola O Ylikorkala, Climacteric 2008 11 409 415 10.1080/13697130802251344 18781486
34. Inflammatory markers in a randomised soya intervention among men. G Maskarinec R Oum AK Chaptman S Ognjanovic, Br J Nutr 2008 1 5 10.1017/S0007114508147389 19079839
35. Effects of raloxifene, hormone therapy, and soy isoflavone on serum high-sensitive C-reactive protein in postmenopausal women. MF Yildiz S Kumru A Godekmerdan S Kutlu, Int J Gynaecol Obstet 2005 90 128 133 10.1016/j.ijgo.2005. 05.005 15970291 (Pubitemid 40981950)
36. Soy-isoflavone-enriched foods and inflammatory biomarkers of cardiovascular disease risk in postmenopausal women: interactions with genotype and equol production. WL Hall K Vafeiadou J Hallund S Bugel C Koebnick M Reimann M Ferrari F Branca D Talbot T Dadd, Am J Clin Nutr 2005 82 1260 1268 16332659 (Pubitemid 43779725)
37. Positive effect of dietary soy in ESRD patients with systemic inflammation-correlation between blood levels of the soy isoflavones and the acute-phase reactants. P Fanti R Asmis TJ Stephenson BP Sawaya AA Franke, Nephrol Dial Transplant 2006 21 2239 2246 10.1093/ndt/gfl169 16766544 (Pubitemid 44295051)
38. Effect of soy nuts on adhesion molecules and markers of inflammation in hypertensive and normotensive postmenopausal women. MM Nasca JR Zhou FK Welty, Am J Cardiol 2008 102 84 86 10.1016/j.amjcard.2008.02.100 18572041
39. Effects of soy or milk protein during a high-fat feeding challenge on oxidative stress, inflammation, and lipids in healthy men. CG Campbell BD Brown D Dufner WG Thorland, Lipids 2006 41 257 265 10.1007/s11745-006-5095-5 16711600
40. Effects of high-dose isoflavones on metabolic and inflammatory markers in healthy postmenopausal women. C Charles J Yuskavage O Carlson M John AS Tagalicud M Maggio DC Muller J Egan S Basaria, Menopause 2008 18981951
41. Lack of effect of isoflavonic phytoestrogen intake on leptin concentrations in premenopausal and postmenopausal women. WR Phipps KE Wangen AM Duncan BE Merz-Demlow X Xu MS Kurzer, Fertil Steril 2001 75 1059 1064 10.1016/S0015-0282(01)01777-0 11384628 (Pubitemid 32522599)
42. Meta-analysis of the effects of soy protein intake on serum lipids. JW Anderson BM Johnstone ME Cook-Newell, N Engl J Med 1995 333 276 282 10.1056/NEJM199508033330502 7596371
43. Body mass index and percent body fat: a meta analysis among different ethnic groups. P Deurenberg M Yap WA van Staveren, Int J Obes Relat Metab Disord 1998 22 1164 1171 10.1038/sj/ijo/0800741 9877251 (Pubitemid 28548536)
44. Molecular mechanisms involved in the growth stimulation of breast cancer cells by leptin. N Yin D Wang H Zhang X Yi X Sun B Shi H Wu G Wu X Wang Y Shang, Cancer Res 2004 64 5870 5875 10.1158/0008-5472.CAN-04-0655 15313931 (Pubitemid 39095588)
45. Effects of soy isoflavones and conjugated equine estrogens on inflammatory markers in atherosclerotic, ovariectomized monkeys. TC Register JA Cann JR Kaplan JK Williams MR Adams TM Morgan MS Anthony RM Blair JD Wagner TB Clarkson, J Clin Endocrinol Metab 2005 90 1734 1740 10.1210/jc.2004-0939 15585561 (Pubitemid 40464046)
46. Genistein, a specific inhibitor of tyrosine-specific protein kinases. T Akiyama J Ishida S Nakagawa H Ogawara S Watanabe N Itoh M Shibuya Y Fukami, J Biol Chem 1987 262 5592 5595 3106339
47. Modulation of human immune and inflammatory responses by dietary fatty acids. DS Kelley, Nutrition 2001 17 669 673 10.1016/S0899-9007(01)00576-7 11448594 (Pubitemid 32633805)